Latest Breaking News On - Director cyrus harmon - Page 2 : vimarsana.com

Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Receives $21 43 Average PT from Brokerages

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have earned a consensus recommendation of “Buy” from the eight brokerages that are covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on the stock […]

Cyrus harmonAnalyst recommendations for olema pharmaceuticalsGoldman sachs groupDimensional fund advisorsSwiss national bankSecurities exchange commissionJump financialPerceptive advisorsFirst light asset managementOlema pharmaceuticals price performanceOlema pharmaceuticals incOlema pharmaceuticalsNews ratings for olema pharmaceuticals dailyGet free reportOne financialDirector cyrus harmon

Olema Pharmaceuticals (NASDAQ:OLMA) Coverage Initiated at The Goldman Sachs Group

The Goldman Sachs Group began coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) in a research report released on Tuesday morning, MarketBeat reports. The firm issued a buy rating and a $24.00 target price on the stock. Other equities analysts have also recently issued reports about the stock. Citigroup started coverage on shares […]

Cyrus harmonAnalyst recommendations for olema pharmaceuticalsRoyal bankNews ratings for olema pharmaceuticals dailyVirtu financialBalyasny asset managementOlema pharmaceuticalsGoldman sachs groupOlema pharmaceuticals incOlema pharmaceuticals company profileCitigroup incOlema pharmaceuticals stock performanceFree reportOne financialGet free reportDirector cyrus harmon

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 8%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonGroup plcSecurities exchange commissionPerceptive advisorsHedge funds weigh in on olema pharmaceuticalsNews ratings for olema pharmaceuticals dailyVanguard group incOlema pharmaceuticals company profileInsider transactions at olema pharmaceuticalsBarclays plcOlema pharmaceuticals incOlema pharmaceuticals stock downOlema pharmaceuticalsGet free reportOne financialPharmaceuticals stock down

Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 8%

Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 8%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonOlema pharmaceuticals incOlema pharmaceuticals trading downOlema pharmaceuticalsRenaissance technologiesJpmorgan chase coNews ratings for olema pharmaceuticals dailyHedge funds weigh in on olema pharmaceuticalsAcadian asset managementBlackrock incPrelude capital managementGet free reportOne financialPharmaceuticals trading downDirector cyrus harmonAsset management

Capital One Financial Comments on Olema Pharmaceuticals, Inc s FY2028 Earnings (NASDAQ:OLMA)

Capital One Financial Comments on Olema Pharmaceuticals, Inc s FY2028 Earnings (NASDAQ:OLMA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cyrus harmonNews ratings for olema pharmaceuticals dailyHedge funds weigh in on olema pharmaceuticalsCitigroup incVirtu financialSecurities exchange commissionBalyasny asset managementOlema pharmaceuticals company profileOlema pharmaceuticals price performanceOlema pharmaceuticals incOlema pharmaceuticalsRoyal bankFree reportCapital one financialOne financialOlema pharmaceutical